Mona Nili, PharmD, PhD

Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, Connecticut

  • 1Article
  • 2025Active
  • 6Collaborators

About

Mona Nili, PharmD, PhD is affiliated with Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, Connecticut. Mona Nili has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2025. Their work focuses on Cognition and Schizophrenia/Schizoaffective Disorders.

Publications

JCP
The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US
Original Research

The Characteristics and Burden of Cognitive Impairments in Schizophrenia in the US

August 11, 2025

Medical Expenditure Panel Survey data showed that over half of adults with schizophrenia report cognitive impairments, which were associated with higher healthcare costs and lower quality of life.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe